Top Growth Trends in the Neuromodulation Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the neuromodulation market size evolved in recent years?
The scale of the neuromodulation market has expanded swiftly in the past few years. It is projected to rise from $6.96 billion in 2024 to $7.68 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. The historical growth can be traced back to factors such as an increase in chronic disorders, medical research, and documented evidence, an inclination for non-invasive therapies from patients, governmental support and financing, extension of indications, plus collaborations and alliances.
What are the predictions for the neuromodulation market size in the coming years?
The neuromodulation market is predicted to experience a surge in growth in the coming years, expected to reach “$11.79 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. The projected acceleration during the forecast period can be linked to the shrinking size of devices, emphasis on neurological illnesses in the elderly, broader use in psychiatry, patient-focused strategies, and worldwide improvement of healthcare accessibility. Major trends to look out for during the forecast period include the incorporation of artificial intelligence (AI), technological advancements, non-invasive neuromodulation methods, closed-loop neuromodulation systems, expanded disease indications for usage, as well as the development of wireless and wearable neuromodulation devices.
Get your neuromodulation market report here!
https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report
What key factors are fueling the growth of the neuromodulation market?
The escalation of neurological conditions is anticipated to be a major driver for the expansion of the neuromodulation market. Neurological conditions are technically classified as issues affecting the brain, nerves spread across the body, and the spinal cord. Neuromodulation provides potential treatment options and the ability to regulate a broad range of neurological diseases like Parkinson’s and Alzheimer’s. For example, in April 2022, the Belgium based European Brain Council, an international health organization reported over 600 neurological diseases and approximately 300 psychiatric conditions. Globally, Alzheimer’s and other forms of dementia affected 50 million individuals. Epilepsy, a common neurological disorder, affected 65 million individuals worldwide. In Europe, dementia was prevalent in 10.5 million people, and this number is projected to rise to 18.7 million by 2050. Therefore, the escalating prevalence of neurological disorders is catalyzing the expansion of the neuromodulation market.
How is the global neuromodulation market divided into key segments?
The neuromodulation market covered in this report is segmented –
1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)
2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial
3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications
4) By End-User: Hospitals, Clinics, Home Healthcare
Subsegments:
1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems
2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp
Who are the key firms paving the way for growth in the neuromodulation market?
Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation
Which trends are expected to transform the neuromodulation market?
Key technological advancements are an emerging trend in the neuromodulation market. Leading businesses in the sector are prioritizing the creation of novel technology solutions to secure their standing. To exemplify, GrayMatters Health, a company based in Israel renowned for its digital self-neuromodulation therapies, debuted an FDA-approved self-neuromodulation therapy labeled Prism for PTSD patients in January 2024. This ground-breaking tool, integrating an EEG cap and software, assists patients in managing their emotional reactions using neurofeedback. The system is configured to improve conventional psychotherapy and pharmacotherapy, giving patients the means to proactively manage their symptoms. Moving on, in December 2022, Abbott Laboratories, a US-based medical devices and healthcare firm, introduced the Eterna spinal cord stimulation (SCS) system, recognized as the smallest, rechargeable implantable spinal cord stimulator. The Eterna SCS utilizes Abbott’s uniquely patented low-dose BurstDR stimulation, the sole SCS waveform innovation with the highest level of clinical proof (1A evidence). It has demonstrated its effectiveness in pain relief, outperforming traditional waveform technology methods by 23%.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142
What regions are contributing significantly to the growth of the neuromodulation market?
North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Neurophysiology Devices And Equipment Global Market Report 2024
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Interventional Neurology Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
